Influenza A virus in Taiwan, 1980-2006: Phylogenetic and antigenic characteristics of the hemagglutinin gene

Journal of Medical Virology

Volumn 81, Issue 8, 2009, Pages 1457-1470

  Wang, Sheng Fan ^a   Lee, Yuan Ming ^a,b   Chan, Yu Jiun ^a,b   Liu, Hsin Fu ^a,c   Yen, Yung Fong ^d   Liu, Wu Tse ^a   Huang, Jason C ^a,d   Chen, Yi Ming Arthur ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

H1N1; H3N2; Hemagglutinin; Influenza; Phylogenetic analysis

Indexed keywords

HEMAGGLUTININ; VACCINE; VIRUS HEMAGGLUTININ;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGENIC VARIATION; ARTICLE; DISEASE SURVEILLANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROTEIN GLYCOSYLATION; REAL TIME POLYMERASE CHAIN REACTION; TAIWAN; UNINDEXED SEQUENCE; VIRUS ISOLATION; VIRUS STRAIN; VIRUS SURVIVAL; WORLD HEALTH ORGANIZATION;

EVOLUTION, MOLECULAR; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; TAIWAN;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 68049089882     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21531     Document Type: Article

References (49)

1. Abe Y, Takashita E, Sugawara K, Matsuzaki Y, Muraki Y, Hongo S. 2004. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J Virol 78:9605-9611. (Pubitemid 39187078)
2. Abed Y, Hardy I, Li Y, Boivin G. 2002. Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada. J Med Virol 67:589-595. (Pubitemid 34747682)
3. Bashirova AA, Geijtenbeek TB, van Duijnhoven GC, van Vliet SJ, Eilering JB, Martin MP, Wu L, Martin TD, Viebig N, Knolle PA, KewalRamani VN, van Kooyk Y, Carrington M. 2001. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 193:671-678. (Pubitemid 32524461)
4. Bragstad K, Nielsen LP, Fomsgaard A. 2008. The evolution of human influenza A viruses from 1999 to 2006: A complete genome study. Virol J 5:40. (Pubitemid 351548819)
5. Carrat F, Flahault A. 2007. Influenza vaccine: The challenge of antigenic drift. Vaccine 25:6852-6862. (Pubitemid 47398929)
6. Chan CH, Lin KL, Chan Y, Wang YL, Chi YT, Tu HL, Shieh HK, Liu WT. 2006. Amplification of the entire genome of influenza A virus H1N1 and H3N2 subtypes by reverse-transcription polymerase chain reaction. J Virol Methods 136:38-43. (Pubitemid 44051574)
7. Cox NJ, Bai ZS, Kendal AP. 1983. Laboratory-based surveillance of influenza A (H1N1) and A (H3N2) viruses in 1980-81: Antigenic and genomic analyses. Bull World Health Organ 61:143-152.
8. de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD. 2000. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 61:94-99.
9. Fournillier A, Wychowski C, Boucreux D, Baumert TF, Meunier JC, Jacobs D, Muguet S, Depla E, Inchauspe G. 2001. Induction of hepatitis C virus E1 envelope protein-specific immuneresponse can be enhanced by mutation of N-glycosylation sites. JVirol 75:12088-12097. (Pubitemid 33115881)
10. Gerhard W, Yewdell J, Frankel ME, Webster R. 1981. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290:713-717. (Pubitemid 11068963)
11. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. 1997. Influenza virus infections in infants. Pediatr Infect Dis J 16:1065-1068.
12. Goffard A, Callens N, Bartosch B, Wychowski C, Cosset FL, Montpellier C, Dubuisson J. 2005. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J Virol 79:8400-8409. (Pubitemid 40853542)
13. Hanna SL, Pierson TC, Sanchez MD, Ahmed AA, Murtadha MM, Doms RW. 2005. N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity. J Virol 79:13262-13274. (Pubitemid 41508141)
14. Hay AJ, Gregory V, Douglas AR, Lin YP. 2001. The evolution of human influenza viruses. Philos Trans R Soc Lond 356:1861-1870.
15. Hillis DM. 1997. Phylogenetic analysis. Curr Biol 7:R129-R131.
16. Hillis DM. 1998. Taxonomic sampling, phylogenetic accuracy, and investigator bias. Syst Biol 47:3-8.
17. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. 2001. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146:2275-2289. (Pubitemid 34682391)
18. Hsieh YC, Chen HY, Yen JJ, Liu DP, Chang LY, Lu CY, Shao PL, Lee CY, Huang LM. 2005. Influenza in Taiwan: Seasonality and vaccine strain match. J Microbiol Immunol Infect 38:238-243.
19. Ikic D, Smerdel S, Manhalter T, Pasini N, Delimar N. 1977. HI antibody response in volunteers vaccinated with live influenza A/New Jersey/76 vaccine. Dev Biol Stand 39:67-71. (Pubitemid 9073227)
20. Jian JW, Chen GW, Lai CT, Hsu LC, Chen PJ, Kuo SH, Wu HS, Shih SR. 2008. Genetic and epidemiological analysis of influenza virus epidemics in Taiwan during 2003 to 2006. J Clin Microbiol 46:1426-1434.
21. Kendal AP, Phillips DJ, Webster RG, Galland GG, Reimer CB. 1981. Effect of test system on the ability of monoclonal antibodies to detect antigenic drift in influenza A(H1N1) virus haemagglutinins. J Gen Virol 54:253-261.
22. Kumar S, Tamura K, Nei M. 2004. MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5:150-163.
23. Lan YC, Liu TT, Yang JY, Lee CM, Chen YJ, Chan YJ, Lu JJ, Liu HF, Hsiung CA, Ho MS, Hsiao KJ, Chen HY, Chen YM. 2005. Molecular epidemiology of severe acute respiratory syndrome-associated coronavirus infections in Taiwan. J Infect Dis 191:1478-1489. (Pubitemid 40563360)
24. Lin YT, Lan YC, Chen YJ, Huang YH, Lee CM, Liu TT, Wong WW, Yang JY, Wang CT, Chen YM. 2007. Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07-BC strains from injection drug users in Taiwan. J Infect Dis 195:1283-1293.
25. Lin JH, Chiu SC, Lee CH, Su YJ, Tsai HC, Peng YT, Wu HS. 2008. Genetic and antigenic analysis of epidemic influenza viruses isolated during 2006-2007 season in Taiwan. J Med Virol 80:316-322.
26. Nicholson KG, Wood JM, Zambon M. 2003. Influenza. Lancet 362:1733-1745.
27. Ohuchi M, Orlich M, Ohuchi R, Simpson BE, Garten W, Klenk HD, Rott R. 1989. Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2). Virology 168:274-280. (Pubitemid 19073305)
28. Ohuchi M, Feldmann A, Ohuchi R, Klenk HD. 1995. Neuraminidase is essential for fowl plague virus hemagglutinin to show hemagglutinating activity. Virology 212:77-83.
29. Plotkin JB, Dushoff J. 2003. Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus. Proc Natl Acad Sci USA 100:7152-7157. (Pubitemid 36706408)
30. Pontoriero AV, Baumeister EG, Campos AM, Savy VL, Lin YP, Hay A. 2003. Antigenic and genomic relation between human influenza viruses that circulated in Argentina in the period 1995-1999 and the corresponding vaccine components. J Clin Virol 28:130-140. (Pubitemid 37040865)
31. Reading PC, Miller JL, Anders EM. 2000. Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol 74:5190-5197.
32. Redlberger M, Aberle SW, Heinz FX, Popow-Kraupp T. 2007. Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/2003 to 2004/ 2005) in Austria. Vaccine 25:6061-6069. (Pubitemid 47077541)
33. Roberts PC, Garten W, Klenk HD.1993. Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin. J Virol 67:3048-3060. (Pubitemid 23143672)
34. Ruigrok RW, Aitken A, Calder LJ, Martin SR, Skehel JJ, Wharton SA, Weis W, Wiley DC. 1988. Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. J Gen Virol 69:2785-2795. (Pubitemid 18269815)
35. Saito T. 2006. Review on replication cycle of influenza virus. Nippon Rinsho 64:1803-1807.
36. Sheth MT, Jhala CI. 1976. Seropatterns of influenza HI antibodies. Indian J Pathol Microbiol 19:1-14.
37. Shih SR, Chen GW, Yang CC, Yang WZ, Liu DP, Lin JH, Chiu SC, Chen HY, Tsao KC, Huang CG, Huang YL, Mok CK, Chen CJ, Lin TY, Wang JR, Kao CL, Lin KH, Chen LK, Eng HL, Liu YC, Chen PY, Lin JS, Wang JH, Lin CW, Chan YJ, Lu JJ, Hsiung CA, Chen PJ, Su IJ. 2005. Laboratory-based surveillance andmolecular epidemiology of influenza virus in Taiwan. J Clin Microbiol 43:1651-1661. (Pubitemid 40491203)
38. Shih YP, Chen CY, Liu SJ, Chen KH, Lee YM, Chao YC, Chen YM. 2006. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus. J Virol 80:10315-10324.
39. Silverstein G. 2006. Preparing for pandemic influenza. Lancet 367:1239-1240.
40. Skehel JJ, Stevens DJ, Daniels RS, Douglas AR, Knossow M, Wilson IA, Wiley DC. 1984. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci USA 81:1779-1783.
41. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, Sebastian R, Chong M, Tam T, De Serres G. 2007. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 25:2842-2851. (Pubitemid 46412567)
42. Smith CB, Cox NJ, Subbarao K, Taber LH, Glezen WP. 2002. Molecular epidemiology of influenza A(H3N2) virus reinfections. J Infect Dis 185:980-985. (Pubitemid 34274442)
43. Tseng RK, Chen HY, Hong CB. 1996. Influenza virus infections in Taiwan from 1979 to 1995. Jpn J Med Sci Biol 49:77-93.
44. Underwood PA, Skehel JJ, Wiley DC. 1987. Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus. J Virol 61:206-208. (Pubitemid 17212463)
45. Vigerust DJ, Ulett KB, Boyd KL, Madsen J, Hawgood S, McCullers JA. 2007. N-linked glycosylation attenuates H3N2 influenza viruses. J Virol 81:8593-8600. (Pubitemid 47242833)
46. Wang SF, Huang JC, Lee YM, Liu SJ, Chan YJ, Chau YP, Chong P, Chen YM. 2008. DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans. Biochem Biophys Res Commun 373:561-566.
47. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol Rev 56:152-179.
48. Wiley DC, Wilson IA, Skehel JJ. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378.
49. Zhang M, Gaschen B, Blay W, Foley B, Haigwood N, Kuiken C, Korber B. 2004. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14:1229-1246. (Pubitemid 39585357)